Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,271,647
-
Share change
-
-538,991
-
Total reported value
-
$58,280,857
-
Put/Call ratio
-
145%
-
Price per share
-
$2.74
-
Number of holders
-
64
-
Value change
-
-$1,637,638
-
Number of buys
-
24
-
Number of sells
-
31
Institutional Holders of OPHTHOTECH CORP - COM (OPHT) as of Q1 2018
As of 31 Mar 2018,
OPHTHOTECH CORP - COM (OPHT) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,271,647 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, D. E. Shaw & Co., Inc., VANGUARD GROUP INC, Stonepine Capital Management, LLC, AJO, LP, RENAISSANCE TECHNOLOGIES LLC, Tamarack Advisers, LP, DEUTSCHE BANK AG\, ACADIAN ASSET MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.